Articles On LBT Innovations (ASX:LBT)

Here’s our fortnightly wrap of the major small cap health stock winners and losers.  One small cap ASX healthcare company has stormed home to top the tables at the end of October. Novita Healthcare (ASX:NHL) shares have exploded 500 per cen...

LBT Innovations Limited (ASX: LBT)- the Australian medical technology company secured its first sales for its APAS® Independence instrument in the European Union. The company sold the APAS® Independence instrument to Labor Dr Wisplinghoff...

Australian medical technology company LBT Innovations (ASX: LBT) has announced the first sale of its APAS (Automatic Plate Assessment System) Independence instrument within the European Union, to Germany’s largest clinical laboratory Labor...

The 10th Annual Australian Microcap Investment Conference will be held on Tuesday 22 October 2019 over two days at the Sofitel Melbourne on Collins. The Conference is Australia’s largest and most comprehensive emerging company investment ev...

Medical technology company LBT Innovations (ASX: LBT) is set to take its artificial intelligence-inspired APAS Independence instrument to Europe after obtaining the highly prized CE Mark certification – a stamp of regulatory approval issued...

The sales focus in Australia continues to be private-sector laboratories as public laboratories remain challenging with no new tenders expected in 2019.

A company may require more funds over and above its retained earnings in order to expand its existing operations, develop new businesses, protect market share or buy another company. The requirement of the company can be fulfilled by either...

At Stockhead we are as amazed as our readers when stocks rise by over 100 per cent in a day. But its a more common occurrence than we thought. There have been 23 stocks that have achieved that feat. The three most common reasons are success...

This second drawdown, together with the cash on hand following a recent $5 million placement, means the company is well funded into 2021.